US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist

10.410
-2.530-19.55%

Close Mar 10 16:00 ET

10.370
-0.040-0.38%

Pre 08:08 ET

63.65MMarket Cap-0.50P/E (TTM)

Aligos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aligos Therapeutics Q4 2024 Earnings Date

Currency：USDMar 10, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	433.33K	629.00K	+195.67K
Beat Est.	-78.43%	-76.54%	+45.15%
EPS	-2.50	-13.08	-10.58
Miss Est.	+54.61%	-40.87%	-423.91%

Analyst Rating

No Data

Aligos Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 0.000	--
--	2025/Q1	-- / 0.000	--
Mar 10, 2025	2024/Q4	629.000K / 433.330K	--
Nov 6, 2024	2024/Q3	1.269M / 333.330K	--
Aug 6, 2024	2024/Q2	1.061M / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 0.000--

--2025/Q1-- / 0.000--

Mar 10, 20252024/Q4629.000K / 433.330K--

Nov 6, 20242024/Q31.269M / 333.330K--

Aug 6, 20242024/Q21.061M / 0.000--

Unlock Free Earnings Estimates

Open Account

Aligos Therapeutics Earnings Reports

Aligos Therapeutics | 10-K: Annual report

Mar 10 08:08 ET

Aligos Therapeutics | 8-K: Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results

Mar 10 08:00 ET

Aligos Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:28 ET

Aligos Therapeutics | 8-K: Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

Nov 6, 2024 16:09 ET